Concepedia

Angeliki Thanasopoulou

AT

7

Publications

870

Citations

7

H-Index

2010

Active since

Affiliations

University Children’s Hospital Basel(Current)

University of Basel

National and Kapodistrian University of Athens

Academy of Athens

Angeliki Thanasopoulou is an author at University Children’s Hospital Basel specializing in cell biology, cancer research, and medicine.

Top concepts

Publications per year

2010–2023

7

Publications

7

PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains

S. Picaud, David Da Costa, Angeliki Thanasopoulou et al. · Cancer Research · 2013 · 244 citations · Full text

, , +20

Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease

Randall J. Bateman, Janice Smith, Michael Donohue et al. · New England Journal of Medicine · 2023 · 239 citations · Full text

Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy

S. Picaud, O. Fedorov, Angeliki Thanasopoulou et al. · Cancer Research · 2015 · 224 citations · Full text

Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction

Angeliki Thanasopoulou, Alexandar Tzankov, Juerg Schwaller · Haematologica · 2014 · 65 citations · Full text

, , +19

Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia

Jarno Kivioja, Angeliki Thanasopoulou, Ashwini Kumar et al. · Leukemia · 2018 · 60 citations

, , +8

Rows per page

1–5 of 7